1. Repurposing Established Compounds to Target Pancreatic Cancer Stem Cells (CSCs)
    Bernhard Renz et al, 2017, Medical Sciences CrossRef
  2. The role of enteric neurons in the development and progression of colorectal cancer
    Glenn Rademakers et al, 2017, Biochimica et Biophysica Acta (BBA) - Reviews on Cancer CrossRef
  3. Antileukemic effects of neurokinin-1 receptor inhibition on hematologic malignant cells
    Samaneh Bayati et al, 2018, Anti-Cancer Drugs CrossRef
  4. Aptamers as targeting ligands and therapeutic molecules for overcoming drug resistance in cancers
    Gang Zhou et al, 2018, Advanced Drug Delivery Reviews CrossRef
  5. The NK1 receptor antagonist NKP608 inhibits proliferation of human colorectal cancer cells via Wnt signaling pathway
    Xiao-Ling Niu et al, 2018, Biol Res CrossRef
  6. Neurokinin-1 receptor (NK1R) inhibition sensitizes APL cells to anti-tumor effect of arsenic trioxide via restriction of NF-κB axis: Shedding new light on resistance to Aprepitant
    Davood Bashash et al, 2018, The International Journal of Biochemistry & Cell Biology CrossRef
  7. Pancreatic cancer stem cells: Perspectives on potential therapeutic approaches of pancreatic ductal adenocarcinoma.
    Claudia Di Carlo et al, 2018, World J Stem Cells CrossRef
  8. The role of sensory innervation in cornea‐lens regeneration
    Kimberly J. Perry et al, 2019, Developmental Dynamics CrossRef
  9. The emerging role of substance P/neurokinin-1 receptor signaling pathways in growth and development of tumor cells
    Hossein Javid et al, 2019, J Physiol Biochem CrossRef
  10. Neurokinin-1 receptor is an effective target for treating leukemia by inducing oxidative stress through mitochondrial calcium overload
    Chentao Ge et al, 2019, Proc Natl Acad Sci USA CrossRef
  11. The NK-1 receptor antagonist L-732,138 induces apoptosis in human gastrointestinal cancer cell lines
    Miguel Muñoz et al, 2017, Pharmacological Reports CrossRef
  12. Evaluation of Receptor Affinity, Analgesic Activity and Cytotoxicity of a Hybrid Peptide, AWL3020
    Joanna Matalińska et al, 2020, Int J Pept Res Ther CrossRef
  13. Colorectal Cancer Invasion and Atrophy of the Enteric Nervous System: Potential Feedback and Impact on Cancer Progression
    Janusz Godlewski et al, 2020, IJMS CrossRef
  14. The Neuropeptide System and Colorectal Cancer Liver Metastases: Mechanisms and Management
    Aldona Kasprzak et al, 2020, IJMS CrossRef
  15. The Neurokinin-1 Receptor Antagonist Aprepitant, a New Drug for the Treatment of Hematological Malignancies: Focus on Acute Myeloid Leukemia
    Miguel Muñoz et al, 2020, JCM CrossRef
  16. Aprepitant Sensitizes Acute Myeloid Leukemia Cells to the Cytotoxic Effects of Cytosine Arabinoside in vitro and in vivo


    Hongzhang Wu et al, 2020, DDDT CrossRef
  17. null
    Matthias Ilmer et al, 2020 CrossRef
  18. The Neurokinin-1 Receptor Antagonist Aprepitant: An Intelligent Bullet against Cancer?
    Miguel Muñoz et al, 2020, Cancers CrossRef
  19. Angiotensin Inhibition, TGF-β and EMT in Cancer.
    Fabian Bernhard Pallasch et al, 2020, Cancers (Basel) CrossRef
  20. MicroRNA-Assisted Hormone Cell Signaling in Colorectal Cancer Resistance
    Crescenzo Massaro et al, 2020, Cells CrossRef
  21. Therapeutic Status and Available Strategies in Pancreatic Ductal Adenocarcinoma
    Gitika Thakur et al, 2021, Biomedicines CrossRef
  22. Identification of the Neurokinin-1 Receptor as Targetable Stratification Factor for Drug Repurposing in Pancreatic Cancer
    Iris Beirith et al, 2021, Cancers CrossRef
  23. Investigation of the Role of Neurokinin-1 Receptor Inhibition Using Aprepitant in the Apoptotic Cell Death through PI3K/Akt/NF-κB Signal Transduction Pathways in Colon Cancer Cells
    Atefeh Ghahremanloo et al, 2021, BioMed Research International CrossRef
  24. Carbohydrate-Based NK1R Antagonists with Broad-Spectrum Anticancer Activity
    Rocío Recio et al, 2021, J. Med. Chem. CrossRef
  25. A Novel Mechanism of Endoplasmic Reticulum Stress‐ and c‐Myc‐Degradation‐Mediated Therapeutic Benefits of Antineurokinin‐1 Receptor Drugs in Colorectal Cancer
    Yue Shi et al, 2021, Adv. Sci. CrossRef
  26. Dramatic Effect of Botulinum Toxin Type A on Hypertrophic Scar: A Promising Therapeutic Drug and Its Mechanism Through the SP-NK1R Pathway in Cutaneous Neurogenic Inflammation
    Shunuo Zhang et al, 2022, Front. Med. CrossRef
  27. IFN ‐α/β‐mediated NK2R expression is related to the malignancy of colon cancer cells
    Huihui Xiang et al, 2022, Cancer Science CrossRef
  28. Neuropeptides in Cancer: Friend and Foe?
    Yue Wu et al, 2022, Advanced Biology CrossRef